Table 1

Demographic, psychopathological and clinical characteristics of study participants

CharacteristicPatients, mean ± SD*
n = 29
Healthy controls, mean ± SD*
n = 20
Statistical testp value
Age, yr27.7 ± 7.230.6 ± 6.6t47 = 1.450.15
Sex, female:male7:226:14χ21 = 0.210.65
Education, yr11.4 ± 2.814.2 ± 2.5U = 101.5≤ 0.001
Smoking, pack-years5.7 ± 13.72.4 ± 4.8U = 239.50.25
Duration of illness, yr7.2 ± 7.1
Age of onset, yr21.0 ± 4.8
Chlorpromazine equivalents, mg/d497.7 ± 407.4
BNSS score
 Apathy (motivation and pleasure)15.5 ± 6.9
 Diminished expression8.6 ± 7.0
SANS score§
 Apathy11.9 ± 5.6
 Diminished expression10.4 ± 9.6
PANSS score
 Positive6.4 ± 2.5
 Negative12.0 ± 5.2
 Disorganized4.7 ± 2.0
 Excited4.5 ± 0.7
 Depressed5.4 ± 2.4
 Total47.7 ± 10.2
CDSS total score2.1 ± 2.5
GAF score58.1 ± 9.6
PSP total score58.2 ± 9.1
Cognition (composite cognitive ability)**−0.85 ± 0.800 ± 0.58t47 = 4.07≤ 0.001
MWT IQ24.5 ± 6.028.7 ± 2.8t47 = 2.890.006
  • BNSS = Brief Negative Symptom Scale; CDSS = Calgary Depression Scale for Schizophrenia; GAF = Global Assessment of Functioning; MWT IQ = Multiple Word Test Intelligence Quotient; PANSS = Positive and Negative Syndrome Scale; PSP = Personal and Social Performance scale; SANS = Scale for the Assessment of Negative Symptoms; SD = standard deviation.

  • * Unless otherwise indicated.

  • All patients were receiving atypical antipsychotics at the time of testing.

  • We investigated potential group differences using 2-sample t tests for continuous data and χ2 tests for categorical data. For data with non-normal distribution, we applied Mann–Whitney U tests.

  • § Apathy includes avolition/apathy and anhedonia/asociality; diminished expression includes affective flattening or blunting and alogia.

  • Positive factor = P1, P3, P5, P9; negative factor = N1, N2, N3, N4, N6, G7; disorganized factor = P2, G5, N11; excited factor = P4, P7, G8, G14; depressed factor = G2, G3, G6.

  • ** Cognition data have been z-transformed based on the data of the control group for each test separately. The composite cognitive ability score was computed as the mean of the z-transformed test scores at the participant level.